Close Menu

NEW YORK – Twist Bioscience reported after the close of the market on Thursday that its first quarter revenues in fiscal year 2021 increased 64 percent year over year.

For the three months ended Dec. 31, 2020, Twist reported $28.2 million in revenues, up from $17.2 million during the same quarter a year ago and beating internal guidance and the average analyst estimate of $25.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.